Jazz Pharmaceuticals

Latest news

• Jazz Pharmaceuticals (JAZZ), The Latest Update Raises A Bigger Question (opens in a new tab)

  Simply Wall Street · Oct 2, 2026

• After a $1.5M September sale, Jazz Pharmaceuticals (NASDAQ: JAZZ) officer proposes another. (opens in a new tab)

  Stock Titan · Oct 1, 2026

• Jazz Pharmaceuticals plc (JAZZ) stock price, news, quote and history (opens in a new tab)

  Yahoo Finance Australia · Sep 30, 2026

• Jazz Pharmaceuticals plc (JAZZ) Stock Price, News, Quote & History (opens in a new tab)

  Yahoo! Finance Canada · Sep 30, 2026

• Q2 Earnings Outperformers: Jazz Pharmaceuticals (NASDAQ:JAZZ) And The Rest Of The Pharmaceuticals Stocks (opens in a new tab)

  Yahoo Finance · Sep 30, 2026

• Nuvation stock, Jazz stock gain new Buys at Citi (NUVB:NYSE) (opens in a new tab)

  Seeking Alpha · Sep 30, 2026

• Jazz Pharmaceuticals Initiated at Buy by Citigroup (opens in a new tab)

  Moomoo · Sep 30, 2026

• Jazz Pharmaceuticals initiated with a Buy at Citi (opens in a new tab)

  tipranks.com · Sep 30, 2026

• Citigroup Initiates Jazz Pharmaceuticals at Buy With $325 Price Target (opens in a new tab)

  marketscreener.com · Sep 30, 2026

• Jazz Pharmaceuticals stock falls 2.43 percent as guidance rises (opens in a new tab)

  AD HOC NEWS · Sep 29, 2026

• What Comes Next for Jazz Pharmaceuticals (NASDAQ:JAZZ)? (opens in a new tab)

  Kalkine Media · Sep 28, 2026

• Jazz Pharmaceuticals stock reports record Q2 revenue growth (opens in a new tab)

  AD HOC NEWS · Sep 24, 2026

• Goldman Sachs initiates Jazz Pharmaceuticals stock with buy rating By Investing.com (opens in a new tab)

  Investing.com UK · Sep 24, 2026

• Jazz Pharmaceuticals PLC (J7Z.HA) Analyst insights, Price targets and Recommendations (opens in a new tab)

  Yahoo Finance UK · Sep 24, 2026

• Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026 (opens in a new tab)

  TradingView · Sep 23, 2026

• Jazz Pharmaceuticals Extends And Reprices $1.895 Billion Term Loan B To 2033 (opens in a new tab)

  TradingView · Sep 23, 2026

• Five more years to repay its loans: Jazz Pharmaceuticals (JAZZ) also lowers borrowing margins. (opens in a new tab)

  Stock Titan · Sep 23, 2026

• Jazz Pharmaceuticals (JAZZ) Gains Put Its Valuation Story Back In Focus (opens in a new tab)

  Simply Wall Street · Sep 23, 2026

• Jazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline Expands (opens in a new tab)

  Yahoo Finance · Sep 20, 2026

• Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B (opens in a new tab)

  Yahoo Finance · Sep 20, 2026

• Ajit Baid Joins Jazz Pharmaceuticals as Executive Director, Head of Marketing – EMD Franchise (opens in a new tab)

  hrtoday.in · Sep 18, 2026

• Should You Buy Jazz Pharmaceuticals Stock After Its Actio Acquisition? (opens in a new tab)

  Yahoo Finance · Sep 18, 2026

• Jazz Pharmaceuticals (JAZZ) Places An $820M Epilepsy Bet (opens in a new tab)

  Yahoo Finance · Sep 17, 2026

• Jazz Pharmaceuticals at Deutsche Bank 2026 Healthcare Summit: ziihera drives growth (opens in a new tab)

  Investing.com · Sep 16, 2026

• Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences (opens in a new tab)

  PR Newswire · Sep 15, 2026

• Jazz Pharmaceuticals Completes $820 Million Upfront Acquisition of Actio Biosciences (opens in a new tab)

  Yahoo Finance · Sep 15, 2026

• Jazz Pharmaceuticals acquires Actio Biosciences for $820M (September 2026) (opens in a new tab)

  Dealroom · Sep 15, 2026

• Jazz Pharmaceuticals (JAZZ) Eyes Ziihera Trials In Breast Colorectal And Lung Cancer (opens in a new tab)

  Yahoo Finance · Sep 14, 2026

• Jazz Pharmaceuticals Sees Meaningful Long-Term Value From Ziihera's Pursuits Beyond GEA, UBS Says (opens in a new tab)

  Yahoo Finance · Sep 11, 2026

• UBS Adjusts Jazz Pharmaceuticals PT to $337 From $315, Maintains Buy Rating (opens in a new tab)

  Yahoo Finance · Sep 11, 2026